Increasing Prevalence of Chronic Disease Is Expanding Size of the Phlebotomy Tubes Market

Advancement in diagnostic tests coupled with the rise in prevalence of chronic disease is expanding Phlebotomy tubes market size. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.2 By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. According to Velano Vascular’s estimation, in the U.S., nearly 800 blood draws are performed every minute. Each blood draw might be associated with multiple phlebotomy tubes. This factor is expected to augment the growth of the Phlebotomy tubes market.

In March 2018, BD, Franklin Lakes, NJ, has launched the CE-marked PaxGene blood circulating cell-free DNA (ccfDNA) collection tube in Western Europe. The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology to help protect healthcare worker safety.

In September 2019, Streck announces the launch of a trusted blood collection tube portfolio, RNA Complete BCTTM, which is now commercially available. The new blood collection tube maintains draw time cell-free RNA concentration while limiting the release of extracellular vesicles, such as exosomes, from blood cells.

Coherent Market Insights celebrating 5th anniversary and offering 2000 USD off on all reports. Let’s celebrate with us.

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/144

Major Key Players Are: Ajosha BioTeklik Pvt. Ltd., Medical Expo, CML Biotech Pvt. Ltd., Gosselin, New MicroMed International Pvt. Ltd., Advacare Pharma, Greiner BioOne, and FL Medical.

Key Questions Answered in the Phlebotomy Tubes Market Report:
1. What is the market size and projected market size for the forecast period?
2. What are the various regions and sub-regions in the market?
3. What opportunities market players can see during the forecast period?
4. What are the drivers, restraints, and growth opportunities of the market?
5. Major players operating in the market?
6. What is the CAGR of the Phlebotomy Tubes Market during the forecast period?

The use of phlebotomy tubes is common in most hospitals. A phlebotomist works with one or more patients and administers and interprets the results of blood tests. Phlebotomy technicians are required in hospitals that do not have specialized blood banking programs. This also includes veterinary institutions and laboratories. Phlebotomy tubes can be identified by the shade of the protective shield or stopper. Usually, specific colors indicate a clinical presentation of some additives. They are classified as blood collection tubes including sclerotherapy tubes, coagulation therapy tubes, hemostatics collection tubes, hemostatics lymphedema collection tubes, dialysis units, and dialysis centers. Typical phlebotomy tubes contain a translucent cover, which makes it easier for doctors and laboratory professionals to see the contents inside the specimen tube. There is typically a dark-colored needle attached to the specimen tube, which is used to draw the sample of blood or urine.

On the basis types of test, the global phlebotomy tubes market is classified into:
Coagulation Blood Test
Anticoagulation Blood Test
Others

On the basis of tube top color, the global phlebotomy tubes market is classified into:
Yellow Top Tube
Light Blue Top Tube
Red Top Tube
Green Top Tube
Gray Top Tube
Others

On the basis of end-user, the global phlebotomy tubes market is classified into:
Hospitals
Diagnostic Centers
Laboratories
Medical Clinics
Others

North America is expected to dominate the global Phlebotomy tubes market owing to the high prevalence of diabetes in the region. According to the Diabetes Research Institute, in 2018, 34.2 million people, or 10.5% of the U.S. population, have diabetes. An estimated 26.8 million people - or 10.2% of the population - had been diagnosed with diabetes. Around 7.3 million people have diabetes but have not yet been diagnosed.

Read more @ https://www.coherentmarketinsights.com/ongoing-insight/phlebotomy-tubes-market-144

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.